Altimmune, Inc. (ALT) on Thursday said that its mid-stage study of Pemvidutide in metabolic dysfunction-associated ...

Study suggests emotional demands at work and in-person confrontations may increase diabetes risk by up to 24%.

Viking Therapeutics initiates VANQUISH phase 3 obesity clinical programme with GLP-1/GIP agonist VK2735: San Diego Thursday, June 26, 2025, 10:00 Hrs [IST] Viking Therapeutics, In ...

People undergoing metabolic and bariatric surgery are less likely to develop psychiatric disorders than those treated with GLP-1 RAs.

Fatty liver disease, increasingly prevalent among young individuals, stems from unhealthy diets, sedentary lifestyles, and obesity. Genetic predisposition, stress, and certain medications also ...